Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Onvapegleukin alfa by Ascendis Pharma for Ovarian Cancer: Likelihood of Approval
Onvapegleukin alfa is under clinical development by Ascendis Pharma and currently in Phase II for Ovarian Cancer. According to GlobalData,...
Onvapegleukin alfa by Ascendis Pharma for Small-Cell Lung Cancer: Likelihood of Approval
Onvapegleukin alfa is under clinical development by Ascendis Pharma and currently in Phase II for Small-Cell Lung Cancer. According to...
Onvapegleukin alfa by Ascendis Pharma for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval
Onvapegleukin alfa is under clinical development by Ascendis Pharma and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer....